Aarey Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE198H01019
  • NSEID: AAREYDRUGS
  • BSEID: 524412
INR
66.05
0.04 (0.06%)
BSENSE

Dec 15

BSE+NSE Vol: 6.88 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "66.05",
    "chg": 0.04,
    "chgp": "0.06%",
    "dir": 1,
    "prev_price": "66.01",
    "mcapval": "187.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE198H01019",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "6.88 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3758818",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3758818.png",
        "date": "2025-12-15 14:00:12",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a sharp decline on 15 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical micro-cap recorded a maximum daily loss of 4.73%, reflecting a significant shift in market sentiment and unfilled supply overwhelming demand."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3755020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3755020.png",
        "date": "2025-12-10 10:00:09",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed intense selling pressure on 10 Dec 2025, hitting its lower circuit limit and registering a maximum daily loss of 5%. The stock’s sharp decline reflects a continuation of recent negative momentum, with investors showing signs of panic selling and a significant volume of unfilled supply weighing on the price."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3753523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3753523.png",
        "date": "2025-12-09 10:00:25",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a sharp decline on 9 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical micro-cap recorded a maximum daily loss of 5.0%, closing at ₹68.24, marking a significant underperformance relative to its sector and the broader market indices."
      },
      {
        "title": "Why is Aarey Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarey-drugs-fallingrising-3752516",
        "imagepath": "",
        "date": "2025-12-09 01:19:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for the past two trading sessions, cumulatively losing 9.75% in value. On 08-Dec, it opened with a significant gap down of 4.88%, signalling immediate bearish sentiment among traders. Intraday volatility remained limited, with the share price fluctuating within a narrow range of just ₹0.09, ultimately settling at the day’s low of ₹72.61. This constrained trading range suggests a lack of strong buying interest to counteract the selling pressure.</p>\n<p>Comparatively, the stock’s performance has lagged behind its sector, underperforming by 2.67% on the day. The Pharmaceuticals sector itself experienced a decline of 2.33%, indicating that Aarey Drugs’ fall is partly reflective of broader sectoral weakness..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3751548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3751548.png",
        "date": "2025-12-08 13:00:11",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a sharp decline on 8 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at ₹71.83, marking a maximum daily loss of 5.01%, amid signs of panic selling and unfilled supply on the bourses."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3746054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3746054.png",
        "date": "2025-12-04 10:00:16",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit price limit of ₹73.49. The pharmaceutical and biotechnology company’s shares declined by 5.0% intraday, marking the maximum permissible daily loss and reflecting a sharp negative sentiment among investors."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3745889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3745889.png",
        "date": "2025-12-04 09:36:20",
        "description": "Aarey Drugs & Pharmaceuticals has encountered significant selling pressure, with the stock registering a sharp decline of 4.99% today and exhibiting a complete absence of buyers. This marks the third consecutive day of losses, reflecting distress selling signals and a challenging trading environment for the pharmaceutical company."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3743529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3743529.png",
        "date": "2025-12-03 10:00:17",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a sharp decline in investor confidence. The stock closed at ₹77.36, marking a maximum daily loss of 5.01%, significantly underperforming both its sector and the broader market indices."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3743401",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3743401.png",
        "date": "2025-12-03 09:50:51",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the pharmaceutical company’s shares continue to underperform relative to broader market indices and sector benchmarks."
      }
    ],
    "total": 544,
    "sid": "933527",
    "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication of the Unaudited Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025",
      "datetime": "13-Nov-2025",
      "details": "Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025",
      "datetime": "13-Nov-2025",
      "details": "Outcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Why is Aarey Drugs falling/rising?

2025-12-09 01:19:04

Recent Price Movement and Market Context

The stock has been under pressure for the past two trading sessions, cumulatively losing 9.75% in value. On 08-Dec, it opened with a significant gap down of 4.88%, signalling immediate bearish sentiment among traders. Intraday volatility remained limited, with the share price fluctuating within a narrow range of just ₹0.09, ultimately settling at the day’s low of ₹72.61. This constrained trading range suggests a lack of strong buying interest to counteract the selling pressure.

Comparatively, the stock’s performance has lagged behind its sector, underperforming by 2.67% on the day. The Pharmaceuticals sector itself experienced a decline of 2.33%, indicating that Aarey Drugs’ fall is partly reflective of broader sectoral weakness...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Newspaper Publication of the Unaudited Financial Results

Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025

13-Nov-2025 | Source : BSE

Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025

Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025

13-Nov-2025 | Source : BSE

Outcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aarey Drugs & Pharmaceuticals Ltd has declared 1% dividend, ex-date: 13 Dec 18

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aarey Drugs & Pharmaceuticals Ltd has announced 1:5 bonus issue, ex-date: 25 Jun 12

stock-summary
RIGHTS

Aarey Drugs & Pharmaceuticals Ltd has announced 2:1 rights issue, ex-date: 19 Jan 12